| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bdf6f7a51ae96a7558399fccfd1b4c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b6833622f033dca31d5e4c5d49ba0c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67c302bc3787c7b64a6c851964c8abba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13a7c25d3a6777d2b07f0b0130f0d4c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b450352fabe6685ce1cbe99c18cdd5e9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36114
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36178 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-321 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05 |
| filingDate |
2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c37be9f87b523c1e03270f018b603e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d1048df8fe5c1bab34c3088e5a26548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8cd929c556d7a31aadaed3180ac09c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a63e68daf75beaa817a311a18466494d |
| publicationDate |
2013-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8538533-B2 |
| titleOfInvention |
Controlled vagal blockage therapy |
| abstract |
Systems and methods for treating at least one of a plurality of disorders characterized at least in part by vagal activity. In embodiments, a method for treating obesity comprises positioning a first electrode on a vagus nerve of an obese patient at a location below a vagal innervation of the heart; treating the patient's obesity by applying an electrical treatment signal to the electrode with the electrical treatment signal having: a frequency selected for the signal to at least partially downregulate nerve impulses on the vagal nerve, wherein the signal has a frequency in excess of 200 Hz, and without simultaneously applying a neural impulse-inducing secondary electrical signal to the vagus nerve on a proximal side of the location whenever the electrical treatment signal is applied; and b) a plurality of on-times separated by a plurality of off-times, the signal applied during the on-times and not applied during the off-times, wherein the duration of the off-times is selected in response to a signal from a sensing electrode representing at least 50% of the activity of the vagal nerve as compared to baseline. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10118035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9358395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712562-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014350632-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10864367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956393-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9968778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765863-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10376145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11197613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10335302-B2 |
| priorityDate |
2003-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |